- Business Wire•2 months agoNichi-Iko Pharmaceutical Co., Ltd. Announces Results of Tender Offer to Purchase All of the Outstanding Shares of Common Stock of Sagent Pharmaceuticals, Inc.
Nichi-Iko Pharmaceutical Co., Ltd. today announced the results of its tender offer to purchase all of the outstanding shares of common stock of Sagent Pharmaceuticals, Inc.
- PR Newswire•2 months agoChemical Financial Set to Join S&P MidCap 400; Supervalu, Shoe Carnival and Eagle Pharmaceuticals to Join S&P SmallCap 600
NEW YORK, Aug. 22, 2016 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices: Chemical Financial Corp. (NASD: CHFC) will replace Supervalu ...
- GlobeNewswire•2 months agoSagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Oxacillin for Injection, USP, 10 g due to presence of iron oxide particulate matter
SCHAUMBURG, Ill., Aug. 17, 2016-- Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of one lot of Oxacillin for Injection, USP, 10 g Lot OXT512 manufactured by Astral SteriTech ...
Sagent Pharmaceuticals, Inc. (SGNT)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||21.74 x 1500|
|Ask||21.78 x 500|
|Day's Range||21.74 - 21.76|
|52wk Range||10.55 - 21.88|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-28.30|
|Avg Vol (3m)||505,988|
|Dividend & Yield||N/A (N/A)|